medroxyprogesterone has been researched along with Invasiveness, Neoplasm in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, G; Aragaki, AK; Cauley, JA; Chlebowski, RT; Crandall, CJ; Manson, JE; McTiernan, A | 1 |
| Miller, DS; Rao, GG | 1 |
| Burnier, F; Cikes, M; Cordey, R; Gloor, E; Hofstetter, J; Knobel, P; Schnyder, P | 1 |
| Geyer, H; Kleine, W; Maier, T; Pfleiderer, A | 1 |
| Mackillop, WJ; Pringle, JF | 1 |
| Manart, FD; Montag, TW | 1 |
1 review(s) available for medroxyprogesterone and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Clinical applications of hormonal therapy in ovarian cancer.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leuprolide; Medroxyprogesterone; Neoplasm Invasiveness; Neoplasm Staging; Nitriles; Ovarian Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles | 2005 |
2 trial(s) available for medroxyprogesterone and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trials.
Topics: Aged; Breast Neoplasms; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Kaplan-Meier Estimate; Mastodynia; Medroxyprogesterone; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Prevalence; Proportional Hazards Models | 2012 |
Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Topics: Adult; Age Factors; Carcinoma, Squamous Cell; Case-Control Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Invasiveness; Risk; Risk Factors; Sexual Behavior; Smoking; Time Factors; Uterine Cervical Neoplasms | 1992 |
4 other study(ies) available for medroxyprogesterone and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy.
Topics: Abdominal Neoplasms; Adult; Endometriosis; Female; Humans; Hysterectomy; Medroxyprogesterone; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Receptors, Estrogen; Receptors, Progesterone; Sarcoma; Time Factors; Tomography, X-Ray Computed; Uterine Neoplasms | 1982 |
Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Papillary; Carcinoma, Squamous Cell; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Multivariate Analysis; Neoplasm Invasiveness; Receptors, Estrogen; Receptors, Progesterone; Sarcoma; Survival Analysis; Uterine Neoplasms | 1990 |
Stage III endometrial carcinoma. A review of 90 cases.
Topics: Adenocarcinoma; Bone Neoplasms; Carcinoma, Squamous Cell; Female; Humans; Medroxyprogesterone; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Radiotherapy Dosage; Retrospective Studies; Time Factors; Uterine Neoplasms | 1985 |
Endolymphatic stromal myosis: surgical and hormonal therapy for extensive venous recurrence.
Topics: Adult; Antineoplastic Agents; Combined Modality Therapy; Delayed-Action Preparations; Estrogens, Conjugated (USP); Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Pelvic Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Renal Veins; Sarcoma; Uterine Neoplasms; Vena Cava, Inferior | 1989 |